Navigate regulatory nuances for your SaMD by following a structured approach to maintain compliance post-release.
Follow this framework to ensure your SaMD conforms to HF standards post-release
read more
Back to team page
Kaitlin Stinson
Director
Kaitlin brings to Bold Insight over 14 years of experience as a human factors engineer at medical device manufacturers. She has extensive experience in diabetes care products, software as medical device (SaMD), and complex drug delivery systems. Kaitlin has a passion for meeting design control and regulatory requirements while executing agile human factors programs of research. She has a BS in Psychology from Ball State University and an MS in Human Factors from Bentley University.
Bold facts
Learn more about
Kaitlin
Something unique about you summed up in one sentence:
I cycled 2,750 miles in one year.
Your favorite part of working at Bold Insight:
The dynamic, knowledgeable, and fun culture.
In your spare time (or if you had spare time), you would absolutely do this:
Ride my bike or go kayaking.
Your favorite city in the world is...and why?
Indianapolis because that’s where I see my family and friends the most.
You cannot start the day without doing this:
Drinking 40 oz of water.
Your ultimate celebrity dinner party guest list would include:
Bethanny Frankel, Lisa Vanderpump, Gizelle Bryant, & Kyle Richards
Long-term personal or professional goal?
Visit as many wine regions across the globe as possible.
Favorite quote:
“What is the cost of lies? It’s not that we’ll mistake them for the truth. The real danger is that if we hear enough lies, then we no longer recognize the truth at all.” ~ Valery Legasov
Read Kaitlin's bold insights
- Integrating FDA's new cybersecurity guidance into medical device human factors engineering processes
- Bold Insight and Eli Lilly and Company co-publish journal article on novel assessment tool to enhance medical device usability
- Bold Insight to launch AI research project at the 2024 HFES Health Care Symposium
Read our team’s latest bold insights
AI Governance: Safeguarding innovation in an evolving regulatory landscape
Discover how leading experts at CES 2024 navigated the complex landscape of AI innovation and risk governance, offering invaluable insights into launching AI products responsibly amidst evolving regulations.
Decoding the user experience of conversational AI
Our CUI expert discusses the complexities of evaluating and improving UX in conversational AI, focusing on factors like personality, context, and conversation flow.
GenAI at the inflection point: Navigating the third wave
2024 is forecasted to be a crucial inflection point for AI, marking the third wave of transformative technologies. Here, we break down learnings on GenAI from our visit to the Consumer Electronics Show.